Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
06/2008
06/05/2008US20080132688 Removing parvovirus or fragments for therapeutic protein mixture using affinity chromatography, isoelectric focusing and filtration
06/05/2008US20080132683 Purification of immunoglobulins from solution (hybridoma cell culture supernatants, animal plasma or sera, or colostrum); solid phase synthesis
06/05/2008US20080132682 Method for manufacturing gelatin with reduced endotoxin content and low endotoxin gelatin
06/05/2008US20080132679 Peptide Capable Of Binding To Insulin-Binding Protein And Adsorbent
06/05/2008CA2672369A1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan
06/05/2008CA2670965A1 Influenza vaccine formulation
06/04/2008EP1927600A1 Homogeneous preparations of IL-28 and IL-29
06/04/2008EP1927584A1 Carrier for separation, method for separation of compound, and method for synthesis of peptide using the carrier
06/04/2008EP1926501A1 Method for stabilisation of a protein solution by addition of hydroxyl radical quenchers and its sterilisation by ionising radiation
06/04/2008EP1794180B1 Peptide cyclisation
06/04/2008EP1592703B1 Method for protein isolation in anoxic conditions
06/04/2008EP1546187B1 Purification process comprising microfiltration at elevated temperatures
06/04/2008CN201068436Y Protein condensation/purification device
06/04/2008CN101190940A Polypeptide with target antithrombotic activity and its preparation method and application
06/04/2008CN100392390C Method of electrophoresing protein
06/03/2008US7381810 Polyphenol oxidase genes from lettuce
06/03/2008US7381804 A colony-stimulating factor hybrid molecules, computer analyzing the three dimensional structure protein, crystallization of the protein
06/03/2008US7381796 Dried blood factor composition comprising trehalose
06/03/2008US7381793 Extracellular matrix-binding proteins from Staphylococcus aureus
06/03/2008US7381705 Inhibitors of hepatitis C virus
06/03/2008US7381572 Using arsenic-mediated labeling to permit orthogonal molecule-specific, site-specific labeling of target molecules, such as proteins, with multiple labels; complex of peptide with tag of a cyanine dye having pendant 2,5-dithia-arsacyclopentane groups
06/03/2008US7381563 Treating peripherial blood mononuclear cells with a suppressive composition for a time sufficient to induce T cell tolerance; and introducing said cells to said patient.
06/03/2008US7381548 Method for producing L-amino acid using bacterium of Enterobacteriaceae family having expression of yafA gene attenuated
06/03/2008US7381531 Apparatus which utilizes a complex of an anti-cocaine aptamer and diethylthiotricarbocyanine dyes to detect cocaine in solution; drug testing; calorimetric sensor
06/03/2008US7381411 Preventing influenza virus cell binding; schizophrenia; diagnosing chronic viral disease associated with cancer development
06/03/2008US7381408 Methods for chemically synthesizing immunoglobulin chimeric proteins
06/03/2008CA2200148C Use of structured depth filters for virus removal
05/2008
05/29/2008WO2008063310A2 Use of cell surface displays in yeast cell catalyst supports
05/29/2008WO2008063093A1 Method for hyperproducing target protein in a plant
05/29/2008WO2008062168A1 Biomolecules
05/29/2008WO2007143161A3 Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods
05/29/2008US20080125582 Methods and compositions for stabilizing prostate specific antigen
05/29/2008US20080125581 Amido-containing metal complexes; sonication; for self-assembling polypeptides; vesicles
05/29/2008US20080125580 Refolding of Recombinant Proteins
05/29/2008US20080125351 Forming water-in-oil emulsion from aqueous phase (water soluble polypeptide and sugar) and oil phase comprising glycolic acid-lactic acid copolymer and solvent, adding silicone oil, hardening, drying; optimizing the silicone oil to polymer ratio to improve bioavailability of peptide drug
05/29/2008US20080125347 Use of host cells in forming modified target molecules, including therapeutic molecules having non-natural amino acids in their sequence; biosynthesis; drug conjugates
05/29/2008US20080124786 Expression vector comprising nucleotide sequences coding diacylglycerol acyltransferases for use in enhancing omega fatty acids production in yarrowia
05/29/2008CA2666234A1 Haptens, hapten conjugates, compositions thereof and method for their preparation and use
05/28/2008EP1924361A1 Laboratory temperature control device with top face
05/28/2008EP1723417A4 C20orf23 as modifier of the igfr pathway and methods of use
05/28/2008EP1723415A4 Pdes as modifiers of the igfr pathway and methods of use
05/28/2008EP1399744B1 Epf receptor assays, compounds and therapeutic compositions
05/28/2008EP0963435B1 Methods for production of proteins
05/28/2008CN101189331A Recombinant protein comprising starch binding domain and use thereof
05/28/2008CN101189252A Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
05/28/2008CN101186940A Process for obtaining insulin or insulin derivatives having correctly bonded cystine bridges
05/28/2008CN101186638A Method for preparing rice basal decay pathogenic bacteriotoxin and application thereof
05/28/2008CN101186634A Refolding method for protein in electrostrictive polymer
05/28/2008CN101185882A High-capacity dewatering electric charge inducing color chromatogram medium and preparation method
05/28/2008CN101185881A Chromatogram medium for immunoglobulin class protein separation purification and preparation method thereof
05/28/2008CN101185874A Surface finish C8 alkyl chain magnetic silicon ball and preparing method and application thereof
05/28/2008CN100390199C Method for extracting insulin type growth factor-1 from fresh pilose antler
05/28/2008CN100390198C Technique for purifying recombined human interferon alpha 1b
05/28/2008CN100390197C Methods of conversion of interferson isoforms and products thereof
05/28/2008CN100390193C Methods and reagents for detecting endotoxin
05/28/2008CN100389821C Stabilized liquid polypeptide-containing pharmaceutical composition
05/28/2008CA2569204A1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan
05/27/2008US7379822 Protein design automation for protein libraries
05/27/2008US7379820 Solution structure of RIP DD and uses thereof
05/27/2008US7378504 Human monoclonal antibodies to Fc gamma receptor I (CD64)
05/27/2008US7378502 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
05/27/2008US7378499 Bacillus thuringiensis Cry8Bb1 toxin with an engineered proteolytic protection site that protects said Cry8Bb1 toxin from proteolytic inactivation in a plant
05/27/2008US7378487 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/27/2008US7378485 A compound containing a polyamide backbone bearing a plurality of ligands that are individually bound to aza nitrogen atoms loacted within the backbone and atleast one ligand is a nucleobase, a DNA intercalator or nucleobase binder
05/27/2008US7378393 Recombinant anticoagulant proteins
05/27/2008US7378276 Method of inducing memory B cell development and terminal differentiation
05/27/2008US7378247 Tumor preferential polypeptide for use in the prevention treatment and diagnosis of cell proliferative disorders
05/27/2008CA2568954A1 Synthesis of spirocyclic glucose-proline hybrids and methods of use
05/27/2008CA2413629C Solid method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same
05/27/2008CA2322616C A process for isolating and purifying viruses, soluble proteins and peptides from plant sources
05/22/2008WO2008058963A1 Immobilization of membrane proteins onto supports via an amphiphile
05/22/2008WO2008058604A1 Use of ionic liquids for membrane protein extraction
05/22/2008US20080119642 Accelerating protein crystal formation via coating crystalization surface with colloidal particles
05/22/2008US20080119638 Human endothelin receptor
05/22/2008US20080119637 Pipette tip column, resin and method of use for extracting an analyte
05/22/2008US20080119569 Polymer-based sustained release device
05/22/2008US20080118912 Polyaminoamide dendrimer encapsulated noble metal nanocluster
05/22/2008CA2669805A1 Use of ionic liquids for membrane protein extraction
05/22/2008CA2668906A1 Membranous protein immobilisation on a carrier using an amphiphile molecule
05/21/2008EP1923398A1 Process for producing a polypeptide
05/21/2008EP1923397A1 Fluorinated amino acids and peptides
05/21/2008EP1923396A2 Microwave-Assisted Peptide Synthesis
05/21/2008EP1495318A4 Method for detecting ligands and targets in a mixture
05/21/2008EP1437937B1 Method for producing a sensor
05/21/2008EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods
05/21/2008DE102006054329A1 Verwendung von Ionischen Flüssigkeiten zur Membranproteinextraktion The use of ionic liquids for membrane protein extraction
05/21/2008CN101182358A Purification method for preparing antler collagen
05/21/2008CN101182348A Preparation method of frozen sericin gel
05/21/2008CN101182347A Phosphorylation method of casein protein
05/20/2008US7375196 PRO19814 antibodies
05/20/2008US7375195 Vectors with DNA encoding pro polypeptides
05/20/2008US7375191 Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
05/20/2008US7375188 Vegetarian protein a preparation and methods thereof
05/20/2008US7375185 Comprises cardiac mysosin light chain kinase protein for use in identification, treatment and prevention of cardiac hypertrophy, cardiomyopathy and congestive heart failure
05/20/2008US7375184 PRO1382 polypeptides
05/20/2008US7375183 identification of differentiation antigen termed mesothelin found on tumor cells, particularly mesotheliomas and ovarian tumor; targeting cells bearing the antigen; its expression level is an indication of the presence of tumor cells
05/20/2008US7375181 Process for purifying glycopeptide phosphonate derivatives
05/20/2008US7375179 PRO19680 polypeptides
05/20/2008US7375084 for treating a bleeding disorder; having at least 25% and less than 98% of fully phosphorylated and sulfated rFIX
05/20/2008US7375078 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond